JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4826
Donegal Group Class A
DGICA
$680M
| $187K | ﹤0.01% |
13,208
+4,422
| +50% | +$64.3K |
2017 Q4
20 quarters
|
|
|
LOVE
4827
LoveSac
LOVE
$213M
| $187K | ﹤0.01% |
8,475
-30,412
| -78% | -$681K |
2018 Q3
17 quarters
|
|
|
VZLA
4828
Vizsla Silver
VZLA
$1.24B
| $187K | ﹤0.01% |
162,400
+36,500
| +29% | +$42.1K |
2022 Q1
3 quarters
|
|
|
QUOT
4829
DELISTED
Quotient Technology Inc
QUOT
| $187K | ﹤0.01% |
54,703
-52,202
| -49% | -$148K |
2017 Q4
20 quarters
|
|
4830
PUT
Capital One
COF
$120B
| $186K | ﹤0.01% |
2,000
-5,000
| -71% | -$492K |
2022 Q2
2 quarters
|
|
|
ETV
4831
Eaton Vance Tax-Managed Buy-Write Opportunities Fund
ETV
$1.74B
| $186K | ﹤0.01% |
+15,181
| New | +$201K |
2022 Q4
0 quarters
|
|
4832
IES Holdings
IESC
$13.9B
| $186K | ﹤0.01% |
10,422
+702
| +7% | +$11.4K |
2017 Q4
20 quarters
|
|
|
ZIMV
4833
DELISTED
ZimVie
ZIMV
| $186K | ﹤0.01% |
19,902
-31,329
| -61% | -$274K |
2022 Q1
3 quarters
|
|
|
DOYU
4834
DouYu International Holdings
DOYU
$130M
| $185K | ﹤0.01% |
13,250
+5,056
| +62% | +$59.1K |
2022 Q1
3 quarters
|
|
4835
Ericsson
ERIC
$30.5B
| $185K | ﹤0.01% |
31,903
-1,712
| -5% | -$10.3K |
2013 Q2
38 quarters
|
|
4836
Franklin FTSE Australia ETF
FLAU
$213M
| $185K | ﹤0.01% |
+7,049
| New | +$182K |
2022 Q4
0 quarters
|
|
4837
Larimar Therapeutics
LRMR
$294M
| $185K | ﹤0.01% |
44,790
+43,664
| +3,878% | +$149K |
2020 Q4
8 quarters
|
|
4838
Prime Medicine
PRME
$626M
| $184K | ﹤0.01% |
+9,874
| New | +$178K |
2022 Q4
0 quarters
|
|
4839
Riley Exploration Permian
REPX
$948M
| $184K | ﹤0.01% |
6,238
-10,775
| -63% | -$306K |
2021 Q2
6 quarters
|
|
|
OMIC
4840
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $184K | ﹤0.01% |
3,050
-463
| -13% | -$31K |
2021 Q2
6 quarters
|
|
|
PEPL
4841
DELISTED
PepperLime Health Acquisition Corporation Class A Ordinary Share
PEPL
| $184K | ﹤0.01% |
17,980
-16,310
| -48% | -$165K |
2022 Q1
3 quarters
|
|
4842
Silvercrest Asset Management
SAMG
$81.7M
| $183K | ﹤0.01% |
9,754
+4,335
| +80% | +$78K |
2017 Q4
20 quarters
|
|
|
XXII
4843
22nd Century Group
XXII
$626K
| – | – |
0
| – | – |
2018 Q2
18 quarters
|
|
4844
Arlo Technologies
ARLO
$1.36B
| $182K | ﹤0.01% |
51,852
+4,029
| +8% | +$16.6K |
2018 Q3
17 quarters
|
|
4845
Capital Southwest
CSWC
$1.51B
| $182K | ﹤0.01% |
10,624
-10,734
| -50% | -$192K |
2022 Q2
2 quarters
|
|
|
GGN
4846
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$820M
| $182K | ﹤0.01% |
50,232
+47,232
| +1,574% | +$165K |
2020 Q3
9 quarters
|
|
4847
PLAYSTUDIOS Inc
MYPS
$56.5M
| $182K | ﹤0.01% |
4,685
+318
| +7% | +$12.8K |
2022 Q2
2 quarters
|
|
4848
Ouster
OUST
$3.29B
| $182K | ﹤0.01% |
21,125
+9,675
| +84% | +$105K |
2021 Q2
6 quarters
|
|
4849
Vivid Seats
SEAT
$35.9M
| $182K | ﹤0.01% |
1,248
+103
| +9% | +$16K |
2022 Q2
2 quarters
|
|
4850
ORIX
IX
$40.1B
| $181K | ﹤0.01% |
11,275
-5,040
| -31% | -$76.6K |
2013 Q2
38 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.